Limpet-M Tablet 2 mg+500 mg is a combination oral antidiabetic medication containing Glimepiride (2 mg) and Metformin Hydrochloride (500 mg). It is specifically formulated for the management of type 2 diabetes mellitus in adults whose blood sugar is inadequately controlled with diet, exercise, and single-agent therapy.

This combination offers dual-action blood glucose control: Glimepiride stimulates insulin secretion from the pancreas, while Metformin improves insulin sensitivity in peripheral tissues and reduces hepatic glucose production. Together, they effectively lower fasting and postprandial blood glucose levels, helping patients achieve better glycemic control.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Mechanism of Action

The dual mechanism of Limpet-M Tablet ensures comprehensive glucose management:

• Glimepiride (2 mg): Stimulates pancreatic beta cells to release insulin in response to elevated blood glucose, promoting glucose uptake by tissues.

• Metformin (500 mg): Enhances insulin sensitivity in muscle and fat tissues, decreases hepatic gluconeogenesis, and improves peripheral glucose utilization.

• Combined effect: Both components work synergistically to stabilize blood sugar levels, minimize post-meal spikes, and reduce overall hyperglycemia risk.

This combination reduces the likelihood of complications associated with chronic hyperglycemia, such as cardiovascular issues, neuropathy, and nephropathy.

Indications

Limpet-M Tablet 2 mg+500 mg is indicated for:

• Type 2 diabetes mellitus: As combination therapy for patients not adequately controlled by diet, exercise, or monotherapy with Glimepiride or Metformin.

• Glycemic control optimization: Helps manage both fasting and postprandial blood glucose.

• Reduction of diabetes-related complications: Long-term use supports better metabolic control, reducing risk of organ damage.

This medication is not suitable for type 1 diabetes, diabetic ketoacidosis, or patients with severe renal or hepatic impairment.

Dosage and Administration

• The typical starting dose is 1 tablet once or twice daily, taken with meals to reduce gastrointestinal side effects from Metformin.

• Swallow the tablet whole with water; do not crush or chew.

• Dosage may be adjusted according to blood glucose levels, HbA1c, and patient response, under medical supervision.

• Regular monitoring of fasting, postprandial glucose, and HbA1c is recommended.

• Continue adhering to dietary measures, exercise, and lifestyle modifications for optimal results.

Precautions

• Use with caution in patients with renal or hepatic impairment; Metformin may increase the risk of lactic acidosis.

• Hypoglycemia may occur due to Glimepiride, especially in elderly patients, missed meals, or concurrent use with other antidiabetic drugs.

• Inform your physician if you have heart disease, adrenal/pituitary disorders, or a history of lactic acidosis.

• Alcohol consumption should be minimized as it may increase hypoglycemia risk or lactic acidosis.

• Consult your doctor before use during pregnancy or lactation.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects may include:

• Hypoglycemia (dizziness, sweating, fatigue, confusion)

• Gastrointestinal disturbances: nausea, vomiting, diarrhea, abdominal discomfort

• Headache

• Mild weight gain due to Glimepiride

Rare but serious side effects may include:

• Severe hypoglycemia requiring immediate intervention

• Lactic acidosis (Metformin-related, very rare but serious)

• Allergic reactions: rash, itching, swelling, or difficulty breathing

• Hematological changes (rare)

Seek immediate medical attention if severe or persistent symptoms occur.

Storage

Store below 30°C in a dry place, protected from sunlight and moisture. Keep out of reach of children.

Limpet-M Tablet 2 mg+500 mg provides effective dual-action therapy for type 2 diabetes, combining the strengths of Glimepiride and Metformin to maintain stable blood sugar, improve insulin function, and reduce long-term complications under medical supervision.